Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2018

01-03-2018 | IM - ORIGINAL

Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure

Authors: Alessia Garramone, Roberto Cangemi, Emanuela Bresciani, Roberto Carnevale, Simona Bartimoccia, Elisa Fante, Marco Corinti, Marco Brunori, Francesco Violi, Giuliano Bertazzoni, Pasquale Pignatelli

Published in: Internal and Emergency Medicine | Issue 2/2018

Login to get access

Abstract

Oxidative stress plays an important role in chronic respiratory diseases where the use of non-invasive ventilation seems to reduce the oxidative damage. Data on acute respiratory failure are still lacking. The aim of the study is to investigate the interplay between oxidative stress and acute respiratory failure, and the role of non-invasive ventilation in this setting. We enrolled 60 patients suffering from acute respiratory failure (PaO2/FiO2 ratio <300): 30 consecutive patients treated with non-invasive ventilation and 30 consecutive patients treated with conventional oxygen therapy. Serum levels of soluble Nox2-derived peptide (sNOX2-dp), a marker of NADPH-oxidase activation, and 8-iso-PGF2α and H2O2, markers of oxidative stress, were evaluated at baseline and after 3 h of treatment. At baseline, higher values of sNOX2-dp, 8-iso-PGF2α and H2O2 are associated with lower values of PaO2/FiO2 ratio (p < 0.001). After 3 h, serum levels of sNOX2-dp, H2O2, and 8-iso-PGF2α significantly decrease in patients treated with non-invasive ventilation, but not in patients treated with conventional oxygen therapy. Delta changes of oxidative stress parameters correlate inversely with the delta changes of PaO2/FiO2 (R = −0.623, p < 0.001 for sNOX2-dp; R = −0.428, p < 0.001 for H2O2; R = −0.548, p < 0.001 for 8-iso-PGF2α). In the acute respiratory failure setting, treatment with non-invasive ventilation reduces the levels of oxidative stress in the first hours. This reduction is associated with an improvement of PaO2/FiO2 ratio as well as in a reduction of NADPH-oxidase activity.
Literature
1.
2.
go back to reference Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R (2016) COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond) 130:1039–1050CrossRef Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R (2016) COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond) 130:1039–1050CrossRef
3.
go back to reference Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRefPubMed Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRefPubMed
4.
go back to reference Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N (2012) Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35:231–236CrossRefPubMed Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N (2012) Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35:231–236CrossRefPubMed
6.
go back to reference Rahman I (2005) The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 4:175–200CrossRefPubMed Rahman I (2005) The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 4:175–200CrossRefPubMed
7.
go back to reference Rahman I, Kinnula VL (2012) Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol 5:293–309CrossRefPubMedPubMedCentral Rahman I, Kinnula VL (2012) Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol 5:293–309CrossRefPubMedPubMedCentral
8.
go back to reference Hasegawa K, Tsugawa Y, Camargo CA Jr, Brown DF (2014) Frequent utilization of the emergency department for acute heart failure syndrome: a population-based study. Circ Cardiovasc Qual Outcomes 7:735–742CrossRefPubMed Hasegawa K, Tsugawa Y, Camargo CA Jr, Brown DF (2014) Frequent utilization of the emergency department for acute heart failure syndrome: a population-based study. Circ Cardiovasc Qual Outcomes 7:735–742CrossRefPubMed
9.
go back to reference Suau SJ, DeBlieux PM (2016) Management of acute exacerbation of asthma and chronic obstructive pulmonary disease in the Emergency Department. Emerg Med Clin N Am 34:15–37CrossRef Suau SJ, DeBlieux PM (2016) Management of acute exacerbation of asthma and chronic obstructive pulmonary disease in the Emergency Department. Emerg Med Clin N Am 34:15–37CrossRef
10.
go back to reference Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185–2196CrossRefPubMed Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185–2196CrossRefPubMed
11.
go back to reference Davidson AC, Banham S, Elliott M et al (2016) BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax 71(Suppl 2):ii1–ii35CrossRefPubMed Davidson AC, Banham S, Elliott M et al (2016) BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax 71(Suppl 2):ii1–ii35CrossRefPubMed
12.
go back to reference Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed
13.
go back to reference O’Driscoll BR, Howard LS, Davison AG, British Thoracic S (2008) BTS guideline for emergency oxygen use in adult patients. Thorax 63(Suppl 6):vi1–vi68PubMed O’Driscoll BR, Howard LS, Davison AG, British Thoracic S (2008) BTS guideline for emergency oxygen use in adult patients. Thorax 63(Suppl 6):vi1–vi68PubMed
14.
go back to reference Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555CrossRefPubMed Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555CrossRefPubMed
15.
go back to reference Pignatelli P, Cangemi R, Celestini A et al (2008) Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. Cardiovasc Res 78:515–522CrossRefPubMed Pignatelli P, Cangemi R, Celestini A et al (2008) Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. Cardiovasc Res 78:515–522CrossRefPubMed
16.
go back to reference Loffredo L, Carnevale R, Cangemi R et al (2013) NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. Int J Cardiol 165:184–192CrossRefPubMed Loffredo L, Carnevale R, Cangemi R et al (2013) NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. Int J Cardiol 165:184–192CrossRefPubMed
17.
go back to reference Cangemi R, Celestini A, Calvieri C et al (2012) Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 98:1063–1066CrossRefPubMed Cangemi R, Celestini A, Calvieri C et al (2012) Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 98:1063–1066CrossRefPubMed
18.
go back to reference Perk J, De Backer G, Gohlke H et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635–1701CrossRefPubMed Perk J, De Backer G, Gohlke H et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635–1701CrossRefPubMed
19.
go back to reference Cangemi R, Calvieri C, Falcone M et al (2015) Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. Am J Cardiol 116:647–651CrossRefPubMed Cangemi R, Calvieri C, Falcone M et al (2015) Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. Am J Cardiol 116:647–651CrossRefPubMed
20.
go back to reference Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, Violi F (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367CrossRefPubMed Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, Violi F (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367CrossRefPubMed
21.
go back to reference Cangemi R, Pignatelli P, Carnevale R et al (2012) Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes 61:1626–1632CrossRefPubMedPubMedCentral Cangemi R, Pignatelli P, Carnevale R et al (2012) Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes 61:1626–1632CrossRefPubMedPubMedCentral
22.
go back to reference Pastori D, Carnevale R, Bartimoccia S et al (2015) Does mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation? Antioxid Redox Signal 23:682–687CrossRefPubMed Pastori D, Carnevale R, Bartimoccia S et al (2015) Does mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation? Antioxid Redox Signal 23:682–687CrossRefPubMed
23.
go back to reference Gregoretti C, Pisani L, Cortegiani A, Ranieri VM (2015) Noninvasive ventilation in critically ill patients. Crit Care Clin 31:435–457CrossRefPubMed Gregoretti C, Pisani L, Cortegiani A, Ranieri VM (2015) Noninvasive ventilation in critically ill patients. Crit Care Clin 31:435–457CrossRefPubMed
24.
go back to reference Allison MG, Winters ME (2016) Noninvasive ventilation for the emergency physician. Emerg Med Clin N Am 34:51–62CrossRef Allison MG, Winters ME (2016) Noninvasive ventilation for the emergency physician. Emerg Med Clin N Am 34:51–62CrossRef
25.
go back to reference Vital FM, Ladeira MT, Atallah AN (2013) Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 5:CD005351 Vital FM, Ladeira MT, Atallah AN (2013) Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 5:CD005351
26.
go back to reference Garcia-de-la-Asuncion J, Garcia-Del-Olmo E, Galan G et al (2016) Glutathione oxidation correlates with one-lung ventilation time and PO2/FiO2 ratio during pulmonary lobectomy. Redox Rep 21:219–226CrossRefPubMed Garcia-de-la-Asuncion J, Garcia-Del-Olmo E, Galan G et al (2016) Glutathione oxidation correlates with one-lung ventilation time and PO2/FiO2 ratio during pulmonary lobectomy. Redox Rep 21:219–226CrossRefPubMed
27.
go back to reference Monneret D, Bonnefont-Rousselot D (2016) Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA. Eur Respir J 47:1012–1014CrossRefPubMed Monneret D, Bonnefont-Rousselot D (2016) Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA. Eur Respir J 47:1012–1014CrossRefPubMed
28.
go back to reference Morton B, Tang L, Gale R, Kelly M, Robertson H, Mogk M, Robin N, Welters I (2015) Performance of influenza-specific triage tools in an H1N1-positive cohort: P/F ratio better predicts the need for mechanical ventilation and critical care admission. Br J Anaesth 114:927–933CrossRefPubMed Morton B, Tang L, Gale R, Kelly M, Robertson H, Mogk M, Robin N, Welters I (2015) Performance of influenza-specific triage tools in an H1N1-positive cohort: P/F ratio better predicts the need for mechanical ventilation and critical care admission. Br J Anaesth 114:927–933CrossRefPubMed
29.
go back to reference Santilli F, D’Ardes D, Davi G (2015) Oxidative stress in chronic vascular disease: from prediction to prevention. Vascul Pharmacol 74:23–37CrossRefPubMed Santilli F, D’Ardes D, Davi G (2015) Oxidative stress in chronic vascular disease: from prediction to prevention. Vascul Pharmacol 74:23–37CrossRefPubMed
Metadata
Title
Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure
Authors
Alessia Garramone
Roberto Cangemi
Emanuela Bresciani
Roberto Carnevale
Simona Bartimoccia
Elisa Fante
Marco Corinti
Marco Brunori
Francesco Violi
Giuliano Bertazzoni
Pasquale Pignatelli
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1750-5

Other articles of this Issue 2/2018

Internal and Emergency Medicine 2/2018 Go to the issue

IM - CASE RECORD

The clinical eye

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.